Skip to content

LIPOCINE INC.: 10-Q filed 2024-08-08

What LIPOCINE INC. reported in its quarterly report filed 2024-08-08 (fiscal Q2 2024): 39 published measures, 111 facts as tagged in accession 0001493152-24-030648.

This filing

Form
10-Q (quarterly report)
Filed
2024-08-08
Fiscal period
fiscal Q2 2024
Accession
0001493152-24-030648 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All LIPOCINE INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2024-06-3023,032,306USD
At 2023-12-3123,001,072USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2024-06-301,823,943USD
At 2023-12-312,631,629USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2024-06-3021,208,363USD
At 2024-03-3123,956,407USD
At 2023-12-3120,369,443USD
At 2023-06-3028,552,011USD
At 2023-03-3131,960,028USD
At 2022-12-3135,634,940USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2024-06-305,553,371USD
At 2023-12-314,771,758USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2024-04-01 to 2024-06-30-3,068,634USD91
2024-01-01 to 2024-06-30444,987USD182
2023-04-01 to 2023-06-30-3,548,629USD91
2023-01-01 to 2023-06-30-7,418,859USD181

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2024-01-01 to 2024-06-30-90,258USD182
2023-01-01 to 2023-06-30-7,237,654USD181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2023-01-01 to 2023-06-304,000USD181

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2024-04-01 to 2024-06-3089,565USD91
2024-01-01 to 2024-06-307,706,738USD182
2023-01-01 to 2023-06-3054,990USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2024-01-01 to 2024-06-30209,340USD182
2023-01-01 to 2023-06-30-11,216USD181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2024-01-01 to 2024-06-30662,531USD182
2023-01-01 to 2023-06-309,115,069USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2024-06-30-199,332,227USD
At 2023-12-31-199,777,214USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2024-04-01 to 2024-06-305,343,922shares91
2024-01-01 to 2024-06-305,329,876shares182
2023-04-01 to 2023-06-305,234,830shares91
2023-01-01 to 2023-06-305,234,830shares181

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2024-04-01 to 2024-06-305,343,922shares91
2024-01-01 to 2024-06-305,459,204shares182
2023-04-01 to 2023-06-305,234,830shares91
2023-01-01 to 2023-06-305,234,830shares181

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2024-04-01 to 2024-06-30-0.57USD/shares91
2024-01-01 to 2024-06-300.08USD/shares182
2023-04-01 to 2023-06-30-0.68USD/shares91
2023-01-01 to 2023-06-30-1.42USD/shares181

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2024-04-01 to 2024-06-30-0.56USD/shares91
2024-01-01 to 2024-06-300.1USD/shares182
2023-04-01 to 2023-06-30-0.68USD/shares91
2023-01-01 to 2023-06-30-1.44USD/shares181

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2024-04-01 to 2024-06-30481USD91
2024-01-01 to 2024-06-30681USD182
2023-01-01 to 2023-06-30200USD181

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2024-06-3099,071USD
At 2023-12-31116,095USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2024-04-01 to 2024-06-30102,265USD91
2024-01-01 to 2024-06-30201,571USD182
2023-04-01 to 2023-06-30164,865USD91
2023-01-01 to 2023-06-30342,637USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2024-04-01 to 2024-06-30-3,292,568USD91
2024-01-01 to 2024-06-30-70,039USD182
2023-04-01 to 2023-06-30-3,955,605USD91
2023-01-01 to 2023-06-30-8,294,239USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2024-06-3022,909,482USD
At 2023-12-3122,861,224USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2024-06-301,823,943USD
At 2023-12-312,631,629USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2024-06-30448,798USD
At 2023-12-311,395,977USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2024-04-01 to 2024-06-303,382,133USD91
2024-01-01 to 2024-06-307,776,777USD182
2023-04-01 to 2023-06-303,955,605USD91
2023-01-01 to 2023-06-308,349,229USD181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2024-04-01 to 2024-06-301,874,721USD91
2024-01-01 to 2024-06-304,693,646USD182
2023-04-01 to 2023-06-302,515,211USD91
2023-01-01 to 2023-06-305,621,521USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2024-06-305,347,940shares
At 2023-12-315,315,830shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2024-06-30220,582,158USD
At 2023-12-31220,171,250USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2024-06-30-9,719USD
At 2023-12-317,259USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2024-06-301,199,215USD
At 2023-12-311,182,191USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2024-06-3023,753USD
At 2023-12-3123,753USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2024-06-301,233,477USD
At 2023-12-311,218,486USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2024-06-30297,051USD
At 2023-12-31773,424USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2024-04-01 to 2024-06-30-3,068,153USD91
2024-01-01 to 2024-06-30445,668USD182
2023-04-01 to 2023-06-30-3,548,629USD91
2023-01-01 to 2023-06-30-7,418,659USD181

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2024-04-01 to 2024-06-30-3,067,749USD91
2024-01-01 to 2024-06-30428,009USD182
2023-04-01 to 2023-06-30-3,567,682USD91
2023-01-01 to 2023-06-30-7,414,350USD181

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2024-04-01 to 2024-06-30-3,068,634USD91
2024-01-01 to 2024-06-30444,987USD182
2023-04-01 to 2023-06-30-3,548,629USD91
2023-01-01 to 2023-06-30-7,418,948USD181

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2024-04-01 to 2024-06-301,507,412USD91
2024-01-01 to 2024-06-303,083,131USD182
2023-04-01 to 2023-06-301,440,394USD91
2023-01-01 to 2023-06-302,727,708USD181

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2024-04-01 to 2024-06-30224,415USD91
2024-01-01 to 2024-06-30515,707USD182
2023-04-01 to 2023-06-30406,976USD91
2023-01-01 to 2023-06-30875,580USD181

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2024-01-01 to 2024-06-30681USD182
2023-01-01 to 2023-06-30656USD181

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2024-01-01 to 2024-06-30209,340USD182
2023-01-01 to 2023-06-30-11,216USD181

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2024-01-01 to 2024-06-30-947,179USD182
2023-01-01 to 2023-06-30-82,801USD181

Inspect the source

Entity
LIPOCINE INC. / CIK 0001535955
Captured
2026-09-20T09:16:59.475Z
SEC response SHA-256
fc6b1f5b710fdd1e50873bb5567fd88fca6380fc2de8a24324b8b2dd733b35ce

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001535955.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))